According to the filed complaint, it is alleged that defendants made numerous materially false and misleading statements and omissions about the quality inventory that Hasbro held throughout the class period, and represented that its rising inventory levels reflected outstanding and anticipated demand, rather than excess supply that outpaced waning demand. As a result of the foregoing, Hasbro common stock traded at artificially inflated prices throughout the class period and defendants' statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. TransMedics Group, Inc. (NASDAQ: TMDX) Johnson Fistel, PLLP is investigating claims on behalf of TransMedics Group, Inc. against certain of its officers and directors. You may be able to pursue changes to the company's corporate governance practices, seek the recovery of funds for the company, and request a court-approved incentive award, all at no cost to you.